IBDEI0NK ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10999,1,4,0)
 ;;=4^E78.1
 ;;^UTILITY(U,$J,358.3,10999,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,11000,0)
 ;;=E78.2^^47^524^42
 ;;^UTILITY(U,$J,358.3,11000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11000,1,3,0)
 ;;=3^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,11000,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,11000,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,11001,0)
 ;;=E78.5^^47^524^43
 ;;^UTILITY(U,$J,358.3,11001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11001,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,11001,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,11001,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,11002,0)
 ;;=I10.^^47^524^44
 ;;^UTILITY(U,$J,358.3,11002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11002,1,3,0)
 ;;=3^Hypertension,Essential
 ;;^UTILITY(U,$J,358.3,11002,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,11002,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,11003,0)
 ;;=I15.8^^47^524^46
 ;;^UTILITY(U,$J,358.3,11003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11003,1,3,0)
 ;;=3^Hypertension,Secondary
 ;;^UTILITY(U,$J,358.3,11003,1,4,0)
 ;;=4^I15.8
 ;;^UTILITY(U,$J,358.3,11003,2)
 ;;=^5007074
 ;;^UTILITY(U,$J,358.3,11004,0)
 ;;=I15.0^^47^524^45
 ;;^UTILITY(U,$J,358.3,11004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11004,1,3,0)
 ;;=3^Hypertension,Renovascular
 ;;^UTILITY(U,$J,358.3,11004,1,4,0)
 ;;=4^I15.0
 ;;^UTILITY(U,$J,358.3,11004,2)
 ;;=^5007071
 ;;^UTILITY(U,$J,358.3,11005,0)
 ;;=I95.1^^47^524^47
 ;;^UTILITY(U,$J,358.3,11005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11005,1,3,0)
 ;;=3^Hypotension,Orthostatic
 ;;^UTILITY(U,$J,358.3,11005,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,11005,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,11006,0)
 ;;=I95.89^^47^524^48
 ;;^UTILITY(U,$J,358.3,11006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11006,1,3,0)
 ;;=3^Hypotension,Other
 ;;^UTILITY(U,$J,358.3,11006,1,4,0)
 ;;=4^I95.89
 ;;^UTILITY(U,$J,358.3,11006,2)
 ;;=^5008079
 ;;^UTILITY(U,$J,358.3,11007,0)
 ;;=I25.9^^47^524^49
 ;;^UTILITY(U,$J,358.3,11007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11007,1,3,0)
 ;;=3^Ischemic Heart Disease,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,11007,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,11007,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,11008,0)
 ;;=I89.0^^47^524^50
 ;;^UTILITY(U,$J,358.3,11008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11008,1,3,0)
 ;;=3^Lymphedema NEC
 ;;^UTILITY(U,$J,358.3,11008,1,4,0)
 ;;=4^I89.0
 ;;^UTILITY(U,$J,358.3,11008,2)
 ;;=^5008073
 ;;^UTILITY(U,$J,358.3,11009,0)
 ;;=R01.1^^47^524^51
 ;;^UTILITY(U,$J,358.3,11009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11009,1,3,0)
 ;;=3^Murmur,Cardia,Unspec
 ;;^UTILITY(U,$J,358.3,11009,1,4,0)
 ;;=4^R01.1
 ;;^UTILITY(U,$J,358.3,11009,2)
 ;;=^5019169
 ;;^UTILITY(U,$J,358.3,11010,0)
 ;;=I21.3^^47^524^52
 ;;^UTILITY(U,$J,358.3,11010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11010,1,3,0)
 ;;=3^Myocardial Infarction,Acute,Unspec Site
 ;;^UTILITY(U,$J,358.3,11010,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,11010,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,11011,0)
 ;;=I25.2^^47^524^53
 ;;^UTILITY(U,$J,358.3,11011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11011,1,3,0)
 ;;=3^Myocardial Infarction,Old
 ;;^UTILITY(U,$J,358.3,11011,1,4,0)
 ;;=4^I25.2
 ;;^UTILITY(U,$J,358.3,11011,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,11012,0)
 ;;=I78.1^^47^524^54
 ;;^UTILITY(U,$J,358.3,11012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11012,1,3,0)
 ;;=3^Nevus,Non-Neoplastic
 ;;^UTILITY(U,$J,358.3,11012,1,4,0)
 ;;=4^I78.1
 ;;^UTILITY(U,$J,358.3,11012,2)
 ;;=^269807
 ;;^UTILITY(U,$J,358.3,11013,0)
 ;;=Z95.0^^47^524^61
